BridgeMD
New treatment option for Popliteal Artery Aneurysm
Official title Prospective Case-control Study in Patients With PAA
ClinicalTrials.gov ID: NCT04188808
What this study is testing
- What it's testing
- The overall objective is to highlight different aspects of care in patients with PAA before and after treatment, and identifying factors that influence the outcome of PAA patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- All patients scheduled for elective surgery of PAA (asymptomatic)
- All patients scheduled for elective surgery of PAD
- Elective open surgery
- Intermittent claudication
- Resting pain or very limited minor tissue loss
You likely can't join if
- Cognitive failure
- Major tissue loss
- severe pain
- if one cannot assimilate information in Swedish and understand the questionnaires
The study team makes the final eligibility decision.
Where it's taking place
- Gothenburg, Sweden
- Stockholm, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gothenburg, Sweden; Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.